Burning rock announces changes to board composition

Guangzhou, china, june 24, 2022 (globe newswire) -- burning rock biotech limited (nasdaq: bnr, the “company” or “burning rock”), a company focused on the application of next generation sequencing (ngs) technology in the field of precision oncology, today announced the resignation of mr. jing rong as a director from the board, and the appointment of dr. licen lisa xu as an independent director to the board.
BNR Ratings Summary
BNR Quant Ranking